Dr. Vanderlugt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2152 Walker Trail
Kalamazoo, MI 49009Phone+1 269-370-5180
Education & Training
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1979 - 1981
Corewell Health – Grand Rapids/Michigan State UniversityInternship, Internal Medicine, 1978 - 1979
University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
MI State Medical License 1979 - 2021
Clinical Trials
- Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects Start of enrollment: 2011 Sep 01
- Study of CXA-10 in Healthy Volunteers Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 1 citationsPharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5-mg Capsules After Single-Dose Administration in Healthy Subjects.James T. VanderLugt, Charles Bon, Dean Knuth, Rhonda Schreiber, Michael D. Ruff
Clinical Pharmacology in Drug Development. 2018-03-01 - 36 citationsAn Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer's DiseaseRaj C. Shah, Dawn C. Matthews, Randolph D. Andrews, Ana W. Capuano, Debra A. Fleischman
Current Alzheimer Research. 2014-06-30 - 147 citationsEfficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac SurgeryJames T. VanderLugt, Thomas Mattioni, Stephen Denker, David F. Torchiana, Thomas S. Ahern
Circulation. 1999-07-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
